2015 Volume 79 Issue 10 Pages 2201-2208
Background: Because the initial (on admission) Glasgow Coma Scale (GCS) examination has not been fully evaluated in comatose survivors of cardiac arrest (CA) who receive therapeutic hypothermia (TH), the aim of the present study was to determine any association between the admission GCS motor score and neurologic outcomes in patients with out-of-hospital CA who receive TH.
Methods and Results: In the J-PULSE-HYPO study registry, patients with bystander-witnessed CA were eligible for inclusion. Patients were divided into 3 groups based on GCS motor score (1, 2–3, and 4–5) to assess various effects on neurologic outcome. Univariate and multivariate analyses were performed to identify independent predictors of good neurologic outcome at 90 days. Of 452 patients, 302 were enrolled. There was a significant difference among the 3 patient groups with regard to neurologic outcome at 90 days in the univariate analysis. Multiple logistic regression analyses showed that the GCS motor score on admission, age >65 years, bystander cardiopulmonary resuscitation, the time from collapse to return of spontaneous circulation, and pupil size <4 mm were independent predictors of a good neurologic outcome at 90 days in cases of CA (GCS motor score, 4–5: odds ratio, 8.18; 95% confidence interval: 1.90–60.28; P<0.01).
Conclusions: GCS motor score is an independent predictor of good neurologic outcome at 90 days in patients sustaining out-of-hospital CA who receive TH. (Circ J 2015; 79: 2201–2208)
In 2002, 2 randomized clinical trials (RCT) reported that therapeutic hypothermia (TH) improved survival and neurologic recovery of comatose survivors of cardiac arrest (CA)1,2 and since then, the use of TH has rapidly emerged as the principle as well as the standard post-resuscitation therapy. However, a recently published RCT concluded that in comatose survivors who have sustained out-of-hospital CA, normothermia management resulted in the same benefit as TH.3 One of the reasons for this discrepancy may be that there is no standardized definition of coma.4 The actual severity of brain injury varies among studies because of the absence of an established modality that enables evaluation of brain injury severity; thus, it is difficult to compare groups of patients treated by TH.1–3 Neurologic examination using the Glasgow Coma Scale (GCS)5 is a universal, simple, and costless procedure, but such a neurologic examination on admission has not been fully evaluated in comatose survivors of CA.1,2,6–13
The aim of the present study was to determine the association between GCS, in particular initial motor score (on admission), and neurologic outcome, in patients with out-of-hospital CA who receive TH.
The present study was conducted using data from the J-PULSE HYPO study registry,14 which contains data from 14 hospitals throughout Japan, collected between January 2005 and December 2009. Medical records of 452 consecutive comatose adult patients who were treated with post-return of spontaneous circulation (ROSC) cooling after an out-of-hospital CA of cardiac etiology were enrolled in the registry (UMIN000001935, Clinical Trials.gov: NCT00901134).14,15 Initial CA rhythm was assessed by emergency medical service (EMS) personnel on arrival at the patient’s location. The definition of ROSC was a palpable pulse in the carotid or radial artery,16 and ROSC before hospital arrival was judged by the EMS providers. The cause of CA was determined clinically by a physician, and CA due to a cause other than any obvious non-cardiac etiology was defined as CA with presumed cardiac etiology.16 The J-PULSE HYPO study was conducted in accordance with the ethical guidelines for epidemiological studies and approved by the ethics committee of each of the 14 participating facilities. We selected patients who met the following inclusion criteria: bystander-witnessed CA, target core temperature of 32–34℃ and a cooling duration of 12–72 h.
GCS EvaluationThe initial GCS score was defined as the score observed immediately after admission to hospital by nurses and/or emergency physicians. Sedatives and paralytics were not administered before admission to hospital, and therefore, the GCS score was not influenced by any drugs.
TreatmentPatients received standard cardiopulmonary resuscitation (CPR) and post-CA care according to the 2005 American Heart Association guidelines.17 If hemodynamic instability persisted after ROSC, despite adequate fluid resuscitation and intravenous infusion of noradrenaline, adrenaline and/or dopamine, intra-aortic balloon pumping and/or cardiopulmonary bypass was performed as applicable.
Core temperature was immediately monitored by the bladder or rectal temperature upon hospital admission and monitored during the post-ROSC cooling period. A target core temperature of 32–34℃ was maintained for 12–72 h, followed by gradual rewarming for 24–72 h.15 Emergency coronary angiography (CAG) was performed if acute coronary syndrome (ACS) was suspected, and coronary reperfusion therapy with percutaneous coronary intervention (PCI) was performed if necessary.
Data Collection and ProcessingData were collected following the Utstein Style guidelines for uniform reporting of laboratory CPR research,16 using software designed exclusively for the J-PULSE HYPO study registry. The following parameters were recorded for each study subject: age, sex, presence or absence of bystander CPR, initial rhythm, time from collapse to ROSC, vital signs on admission, mechanical circulation support after ROSC, cooling, CA due to ACS, CAG, PCI, cooling method, interval, overcooling, duration, rewarming duration, and neurologic outcome.
Study EndpointsThe primary endpoints were to assess the effect of GCS motor score on admission and to identify factors associated with a favorable neurologic outcome at 90 days after CA [Glasgow-Pittsburgh cerebral performance category (GP-CPC)16 of 1 or 2].6,18
Statistical AnalysisStudy patients were divided into 2 groups on the basis of neurologic outcome (GP-CPC 1–2 and 3–5, respectively), and 3 groups on the basis of initial GCS motor score (1, 2–3, and 4–5, respectively). Baseline characteristics were compared using the Mann-Whitney U-test for continuous variables and the Fisher’s test for categorical variables as applicable. Comparisons of GCS motor score among the 3 groups were made using analysis of variance and Wilcoxon test for continuous variables and the χ2 test in binary data as applicable.
Univariate and multivariate logistic regression analyses were performed for the primary endpoints. Multivariate analysis was adjusted for possible confounders [age, sex, presence or absence of bystander CPR, the time from collapse to ROSC, pupil size <4 mm, initial rhythm (shockable), and GCS motor score on admission]. Variables with a probability (P) value <0.05 in the univariate analyses and variables of clinical significance were included in the model.1,2,15 Statistical analysis was performed using the JMP version 11 statistical software (SAS Institute, Inc, Cary, NC, USA).
Of the 452 comatose adult patients treated with post-ROSC cooling and enrolled in the J-PULSE HYPO study registry, 376 met the inclusion criteria. Of these, 4 were excluded because the collapse-to-ROSC interval could not be determined; 10 patients were not eligible because the GCS motor score on admission could not be determined; another 60 patients were excluded because their neurologic outcome could not be determined (Figure 1). The remaining 302 patients were divided into 3 groups on the basis of the GCS motor score on admission as indicated.
Enrolment of study patients: adult comatose survivors of out-of-hospital cardiac arrest who received therapeutic hypothermia. GCS, Glasgow Coma Scale; EMS, emergency medical service; ROSC, return of spontaneous circulation.
Of the 302 patients enrolled, 80.8% were male. Analysis of initial (on admission) GCS scores revealed that 97.7% of the patients exhibited an eye score of 1 and 99.7% had a verbal score ≤2. A total of 173 patients were identified as having a CPC of 1–2 at 90 days (Table 1).
Total (n=302) | |
---|---|
Age >65 years (%) | 116 (38.4) |
Male (%) | 244 (80.8) |
Bystander CPR (%) | 164 (54.3) |
Initial rhythm (shockable) (%) | 238 (78.8) |
Time intervals | |
Time from collapse to ROSC (min) | 25 (17–39) |
Vital signs on admission | |
Glasgow Coma Scale | |
Eye score 1 (%) | 295 (97.7) |
Verbal score ≤2 (%) | 301 (99.7) |
Motor score | |
1 (%) | 249 (82.5) |
2–3 (%) | 30 (9.9) |
4–5 (%) | 23 (7.6) |
SBP (mmHg) | 130 (110–163) |
Heart rate (beats/min) | 99 (84–120) |
Core body temperature | 35.8 (35.0–36.4) |
Pupil size <4 mm (%) | 123 (40.7) |
Mechanical circulation support after ROSC | |
Intra-aortic balloon pumping (%) | 117 (38.7) |
Cardiac arrest because of ACS (%) | 185 (61.3) |
Cooling | |
External cooling only (%) | 72 (23.8) |
Time interval from induction of cooling to target core temperature <4 h (%) | 193 (63.9) |
Cooling duration ≤24 h (%) | 134 (44.4) |
Rewarming duration, within 2 days (%) | 198 (65.6) |
Emergency coronary angiography (%) | 62 (20.5) |
Percutaneous coronary intervention (%) | 142 (47.0) |
Outcome | |
GP-CPC 1 | 158 (52.3) |
GP-CPC 2 | 15 (5.0) |
GP-CPC 3 | 22 (7.3) |
GP-CPC 4 | 33 (10.9) |
GP-CPC 5 | 74 (24.5) |
Data are presented as median (interquartile range, IQR) for continuous variables and n (%) for categorical variables. ACS, acute coronary syndrome; CPR, cardiopulmonary resuscitation; GP-CPC, Glasgow-Pittsburgh cerebral performance category; ROSC, return of spontaneous circulation; SBP, systolic blood pressure.
Comparison of patients in the favorable and unfavorable outcome groups revealed that age >65 years, initial rhythm (shockable), the time from collapse to ROSC, GCS motor score, and pupil size <4 mm differed significantly (Table 2A).
GP-CPC 1–2 at 90 days (n=173) |
GP-CPC 3–5 at 90 days (n=129) |
P value | |
---|---|---|---|
A. The time from collapse to arrival in the ED by EMS | |||
Age >65 years (%) | 49 (28.3) | 67 (52.0) | <0.01 |
Male (%) | 141 (81.5) | 103 (79.8) | 0.77 |
Bystander CPR (%) | 96 (55.5) | 68 (52.7) | 0.64 |
Initial rhythm (shockable) (%) | 153 (88.4) | 85 (65.9) | <0.01 |
Time intervals | |||
Time from collapse to ROSC (min) | 20 (14–30) | 34 (23–50) | <0.01 |
Vital signs on admission | |||
Glasgow Coma Scale | |||
Eye score 1 (%) | 167 (96.5) | 128 (99.2) | 0.24 |
Verbal score ≤2 (%) | 173 (100) | 128 (99.2) | 0.43 |
Motor score | <0.01 | ||
1 (%) | 130 (75.1) | 119 (92.3) | |
2–3 (%) | 23 (13.3) | 7 (5.4) | |
4–5 (%) | 20 (11.6) | 3 (2.3) | |
SBP (mmHg) | 132 (110–170) | 122 (110–147) | 0.18 |
Heart rate (beats/min) | 100 (85–120) | 95 (80–120) | 0.49 |
Core body temperature (℃) | 36 (35.1–36.4) | 35.6 (35–36.2) | 0.06 |
Pupil size <4 mm (%) | 87 (50.3) | 36 (27.9) | <0.01 |
B. The time period after admission | |||
Mechanical circulation support after ROSC | |||
Intra-aortic balloon pumping (%) | 59 (34.1) | 58 (44.9) | 0.06 |
Cardiac arrest due to ACS (%) | 102 (59.0) | 83 (64.3) | 0.40 |
Cooling | |||
External cooling only (%) | 48 (27.8) | 24 (18.6) | 0.08 |
Time interval from induction of cooling to target core temperature <4 h (%) |
101 (58.3) | 92 (71.3) | 0.02 |
Cooling duration ≤24 h (%) | 72 (41.6) | 62 (48.1) | 0.22 |
Rewarming duration, within 2 days (%) | 111 (64.2) | 87 (67.4) | 0.62 |
Emergency coronary angiography (%) | 28 (16.2) | 34 (26.4) | 0.04 |
Percutaneous coronary intervention (%) | 77 (44.5) | 65 (50.4) | 0.35 |
Data are presented as median (IQR) for continuous variables and n (%) for categorical variables. ED, emergency department; EMS, emergency medical service; IQR, interquartile range. Other abbreviations as in Table 1.
The number of patients with a time interval <4 h from induction of cooling to reaching target core temperature was significantly lower among patients with a favorable outcome than among those with an unfavorable outcome (53.4% vs. 71.3%, P=0.02) (Table 2B).
Comparison of GCS Motor Score Groups (Between 1 and 2–3 and Between 1 and 4–5) According to Time From Collapse to Arrival in the ED by EMSThere were significant differences among the 3 groups with regard to the time from collapse to ROSC and pupil diameter <4 mm.
Significant differences were observed between patients with a GCS motor score of 1 and those with a score of 2–3 with regard to the time from collapse to ROSC and pupil diameter <4 mm. There was also a significant difference in the time from collapse to ROSC between patients with a GCS motor score of 1 and those with a score of 4–5 (Table 3A).
GCS: M1 (n=249) |
GCS: M2–3 (n=30) |
OR (95% CI) |
P value | GCS: M4–5 (n=23) |
OR (95% CI) |
P value | P value*,** | |
---|---|---|---|---|---|---|---|---|
A. The time from collapse to arrival in the ED by EMS | ||||||||
Age >65 years, n (%) | 99 (40.0) | 12 (40.0) | 1.01 (0.47–2.19) |
1.00 | 5 (21.7) | 0.42 (0.15–1.17) |
0.11 | 0.21* |
Male, n (%) | 199 (79.9) | 24 (80) | 1.01 (0.39–2.59) |
1.00 | 21 (91.3) | 2.64 (0.60–11.63) |
0.27 | 0.35* |
Bystander CPR, n (%) | 110 (44.2) | 18 (60.0) | 1.90 (0.88–4.10) |
0.12 | 10 (43.5) | 0.97 (0.41–2.30) |
1.00 | 0.25* |
Initial rhythm (shockable), n (%) | 192 (77.1) | 26 (86.7) | 1.93 (0.65–5.76) |
0.34 | 20 (87.0) | 1.98 (0.57–6.9) |
0.43 | 0.26* |
Time intervals | ||||||||
Time from collapse to ROSC (min) | ||||||||
Median (IQR) | 28 (19–43) |
16.5 (12–20) |
<0.01 | 17 (13–31) |
<0.01 | <0.01* | ||
Mean (SD) | 33.4 (25.8) | 17.8 (7.5) | <0.01 | 24.4 (24.1) | 0.11 | <0.01* | ||
Vital signs on admission | ||||||||
SBP (mmHg) | ||||||||
Median (IQR) | 132 (110–162) |
121 (110–149) |
0.33 | 143 (110–176) |
0.43 | 0.43* | ||
Mean (SD) | 136 (41) | 128 (30) | 0.34 | 147 (48) | 0.25 | 0.25* | ||
Heart rate (beats/min) | ||||||||
Median (IQR) | 102 (86–129) |
90 (79–110) |
0.08 | 100 (86–121) |
0.92 | 0.19* | ||
Mean (SD) | 104 (29) | 96 (23) | 0.15 | 105 (26) | 0.89 | 0.31* | ||
Core body temperature (℃) | ||||||||
Median (IQR) | 35.8 (35–36.3) |
36.1 (35.5–36.4) |
0.30 | 36 (35.1–36.6) |
0.33 | 0.39* | ||
Mean (SD) | 35.7 (1.0) | 35.9 (0.7) | 0.28 | 36.0 (1.1) | 0.22 | 0.29* | ||
Pupil diameter <4 mm, n (%) | 92 (37.0) | 21 (70.0) | 3.68 (1.61–8.38) |
<0.01 | 10 (43.5) | 1.31 (0.54–3.16) |
0.65 | <0.01 |
B. The period after admission | ||||||||
Mechanical circulation support after ROSC | ||||||||
Intra-aortic balloon pumping (%) |
100 (40.2) | 8 (26.7) | 1.85 (0.79–4.31) |
0.17 | 14 (60.9) | 1.04 (0.44–2.50) |
1.00 | 0.35** |
Cardiac arrest due to ACS (%) |
157 (63.1) | 16 (53.3) | 0.67 (0.31–1.43) |
0.32 | 12 (52.2) | 0.64 (0.27–1.51) |
0.37 | 0.39** |
Cooling | ||||||||
External cooling only (%) | 57 (22.9) | 6 (20.0) | 0.84 (0.33–2.16) |
0.82 | 9 (39.1) | 2.17 (0.89–5.26) |
0.12 | 0.22** |
Time interval from induction of cooling to target core temperature <4 h (%) |
165 (66.2) | 15 (50.0) | 0.51 (0.24–1.09) |
0.11 | 13 (56.5) | 0.66 (0.28–1.57) |
0.37 | 0.17** |
Cooling duration ≤24 h (%) | 114 (45.8) | 14 (46.7) | 1.08 (0.50–2.34) |
1.00 | 6 (26.1) | 2.35 (0.87–6.34) |
0.10 | 0.52** |
Rewarming duration, within 2 days (%) |
165 (66.3) | 16 (53.3) | 0.58 (0.27–1.25) |
0.16 | 17 (73.9) | 1.44 (0.55–3.79) |
0.64 | 0.26** |
Emergency coronary angiography (%) |
199 (80.0) | 22 (73.3) | 1.45 (0.61–3.44) |
0.47 | 19 (82.6) | 0.84 (0.27–2.57) |
1.00 | 0.66** |
Percutaneous coronary intervention (%) |
129 (51.8) | 19 (63.3) | 1.61 (0.73–3.51) |
0.25 | 12 (52.2) | 1.01 (0.43–2.39) |
1.00 | 0.48** |
(A) P value: Mann-Whitney U-test in upper column, t-test in lower column. *In continuous data, Wilcoxon test among 3 groups for GCS motor scores in upper column, ANOVA in lower column. χ2 test among 3 groups for GCS motor scores in binary data. (B) Data are presented as median (interquartile range, IQR) for continuous variables and n (%) for categorical variables. **χ2 test among 3 groups for GCS motor scores in binary data. CI, confidence interval; OR, odds ratio. Other abbreviations as in Tables 1,2.
There was no significant difference between patients with a GCS motor score of 1 and those with a score of 2–3 or 4–5 according to the time period after admission (Table 3B).
Association Between GCS Motor Score on Admission and Neurologic OutcomeThere was a significant difference among the 3 groups with regard to favorable neurological outcome (GP-CPC, 1–2) at 90 days [GCS motor score 1, n=130 (52.2%); score 2–3, n=23 (76.7%); score 4–5, n=20 (87.0%); P<0.01; Figure 2].
Association between Glasgow Coma Scale (GCS) motor score and neurologic outcome.
Multiple logistic regression analysis showed that GCS motor score on admission, age >65 years, presence or absence of bystander CPR, the time from collapse to ROSC, pupil size <4 mm, and initial rhythm (shockable) were independent predictors of good neurologic outcome at 90 days in cases of CA (Table 4).
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | Adjusted OR | 95% CI | P value | |
GCS motor score on admission | ||||||
M1 (reference) | 1 | 1 | ||||
M2–3 | 3.00 | 1.30–7.81 | <0.01 | 1.62 | 0.62–4.64 | 0.33 |
M4–5 | 6.12 | 2.03–26.36 | <0.01 | 8.18 | 1.90–60.28 | <0.01 |
Age >65 years | 0.30 | 0.17–0.53 | <0.01 | |||
Male | 1.03 | 0.50–2.09 | 0.94 | |||
Bystander CPR | 1.78 | 1.00–3.19 | 0.046 | |||
Time from collapse to ROSC (min) | 1.03 | 1.02–1.05 | <0.01 | |||
Pupil size <4 mm | 2.39 | 1.32–4.40 | <0.01 | |||
Initial rhythm (shockable) | 3.93 | 2.01–7.92 | <0.01 |
Abbreviations as in Tables 1,3.
There was a significantly better neurologic outcome in patients with pupil <4 mm compared with those with pupil ≥4 mm among the patients with GCS motor score 1 (70% vs. 41.4%, P<0.01) (Table 3A).
(A) Comparison of pupil size <4 mm and ≥4 mm groups with regard to neurologic outcome among patients with GCS motor score 1. (B) Comparison of initial rhythm shockable and unshockable groups with regard to neurologic outcome among patients with GCS motor score 1. GCS, Glasgow Coma Scale.
There was a significantly better neurologic outcome in the group compared with the ≥4 mm pupil group in patients with GCS motor score 1 (60.9% vs. 22.8%, P<0.01) (Table 3B).
In the current study, a favorable neurologic outcome increased in proportion to initial GCS motor score, and the initial GCS motor score was determined to be a factor.
Neurologic examinations, such as the FOUR score and the recently published Pittsburgh Cardiac Arrest Category, assist in predicting the outcome of CA survivors; however, such examinations are performed 1–2 days after CA and 6 h after ROSC, respectively, and comprise multiple examinations.19,20 Meanwhile, in clinical practice, the decision to initiate TH should not be delayed, so an evaluation of initial (on admission) GCS motor score applicability is valuable.
GCS was introduced by Jennett and Teasdale in 19745 and has been shown to be particularly useful for monitoring the severity of consciousness in patients with traumatic brain injury.21 Because comatose survivors of CA are intubated and eye opening does not always represent intact consciousness (as in a persistent vegetative state), the motor component of GCS is more useful and accurate than the GCS in predicting neurologic outcome.21,22 Schefold et al demonstrated that simple GCS monitoring on the day after TH is useful for predicting neurologic outcome.23 However, following TH, neurologic examinations are challenging because of the use of sedative and paralytic agents in TH.8,18,24 Absent or extensor motor responses are no longer reliable predictors of a poor outcome following TH; Greer et al reported that 8.1% of patients with absent or extensor motor responses on day 3 after admission achieved good outcomes.4 Rossetti et al prospectively evaluated 111 patients treated with TH and observed that a poor motor response on day 3 after admission had a false positivity rate of 24% with regard to predicting poor outcome,6 but others have reported false positivity rates of 10–17%.7,8,24 Therefore, because sedatives and paralytics were not administered on admission in the current study, it is theoretically reasonable that the admission GCS motor score of these comatose CA survivors may reliably predict neurologic outcome.
Most of the studies regarding the efficacy of TH in comatose CA survivors did not report the admission GCS motor scores,1,2,6–8 but 2 did. Greer et al examined 200 comatose survivors of CA, but 152 (85%) patients died subsequent to withdrawal of life-sustaining therapies, and the rate of CA patients who received TH was unknown; therefore, any association between initial GCS motor score and neurologic outcome in patients with CA who received TH could not be investigated.4 A recently published RCT comparing normothermia and TH for comatose survivors of out-of-hospital CA performed by Nielsen et al3 evaluated GCS motor score on admission. Although they reported similar GCS motor scores in the study groups, the association between GCS motor score and neurologic outcome remains unknown. The results of the present study indicated that GCS motor score monitoring on admission may provide information sufficient to identify patients who are more likely to achieve a favorable neurologic outcome following CA.
Our data do not support early termination of aggressive support, including TH, on the basis of a single test of initial GCS motor score; even patients with the worst GCS motor score (1) may have a 52.2% probability of good neurologic outcome after receiving TH. In patients with initial GCS motor score 1, the pupil size on admission (<4 mm or ≥4 mm) and initial rhythm (shockable or not) are useful information for predicting the neurologic outcome after receiving TH.
Thus, further studies are required to examine the specific benefits of TH for patients with an initial GCS motor score of 1. Initial GCS motor score examination can at least provide baseline objective prognostic data for discussions with surrogate decision makers.
Study LimitationsFirst, the neurologic outcomes of 60/376 patients could not be obtained because of patient discharge or transfer. Of those 60 patients, 32 were confirmed as cerebral performance category 1 on day 30. We made a comparison of our analyzed data and the missing cases with regard to baseline characteristics and confirmed that there was no significant difference between the 2 groups. Furthermore, we made a comparison of neurologic outcome at 30 days between our analyzed data and the missing cases for each initial GCS motor score 1, 2–3 and 4–5 groups, and there was no significant difference in the neurologic outcomes at 30 days.
Second, our survey did not evaluate GCS following TH; therefore, we did not compare the efficacy of GCS before and after TH. Third, GCS motor scores do not have equal differences. For example, the difference between M5 and M4, and M4 and M3 is not equal. Fourth, the database is relatively old, so patients were not resuscitated according to current guidelines.
GCS motor score on admission is an independent predictor of good neurologic outcome at 90 days for patients who sustain out-of-hospital CA and receive TH. The GCS motor score should be evaluated in the ED when initially examining patients with out-of-hospital CA.
This study was supported by a research grant for Cardiovascular Disease (H19-Shinkin-03: a study related to the establishment of a prehospital system in acute myocardial infarction and stroke) from the Ministry of Health, Labour and Welfare of Japan.
We have no conflicts of interest to declare.